XML 51 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statement of Cash Flows (USD $)
In Millions, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Cash Flows from Operating Activities    
Net income including noncontrolling interest $ 1,225 $ 1,147
Adjustments to reconcile net income including noncontrolling interest to net cash provided by operating activities    
Depreciation and amortization 350 336
Company pension and postretirement contributions (42) (68)
Company pension and postretirement expense 98 138
Stock-based compensation expense 122 103
Deferred income taxes (83) 61
Excess tax benefits from stock-based compensation (51) (34)
Changes in assets and liabilities    
Accounts receivable (347) (447)
Inventories (131) (28)
Accounts payable 84 97
Accrued income taxes (current and long-term) 135 99
Product and other insurance receivables and claims (25) (8)
Other - net (243) (402)
Net cash provided by operating activities 1,092 994
Cash Flows from Investing Activities    
Purchases of property, plant and equipment (PP&E) (293) (324)
Proceeds from sale of PP&E and other assets 3 10
Purchases of marketable securities and investments (601) (1,767)
Proceeds from maturities and sale of marketable securities and investments 599 1,671
Other investing 5 5
Net cash used in investing activities (287) (405)
Cash Flows from Financing Activities    
Change in short-term debt - net 466 (13)
Repayment of debt (maturities greater than 90 days) (64) (5)
Proceeds from debt (maturities greater than 90 days) 172 9
Purchases of treasury stock (1,708) (805)
Proceeds from issuance of treasury stock pursuant to stock option and benefit plans 267 738
Dividends paid to shareholders (566) (440)
Excess tax benefits from stock-based compensation 51 34
Other - net (17) (4)
Net cash used in financing activities (1,399) (486)
Effect of exchange rate changes on cash and cash equivalents (33) (58)
Net increase (decrease) in cash and cash equivalents (627) 45
Cash and cash equivalents at beginning of year 2,581 2,883
Cash and cash equivalents at end of period $ 1,954 $ 2,928